Skip to content

EXOZ EXOZ Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

Ginkgo Bioworks logo
Ginkgo BioworksDNA
Upexi logo
UpexiUPXI
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
XCF Global, Inc. Class A Common Stock logo
XCF Global, Inc. Class A Common StockSAFX

Other financials

Income statement

See full
Revenue$17.5K
Operating income-$2.4M-22.4%
Net income-$2.4M-27.7%
EPS (diluted)-$0.28-27.3%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation

See full
Market cap$76.8M-5.6%
Enterprise value$76.57M+1.0%
P/S1,096.1×

Profitability

See full
Operating margin-14,489.6%
Net margin-2,909.1%
FCF margin-10,117.8%

Returns & leverage

See full
Return on equity-185.8%
Debt / equity0.8×+0.6×
Current ratio1.3×-5.2×

Where this comes from

Reported directly by EXOZ in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EXOZ's preferred stock, shares authorized?
EXOZ (EXOZ) reported preferred stock, shares authorized of $5M in Q1 2026.
How has EXOZ's preferred stock, shares authorized changed year-over-year?
EXOZ's preferred stock, shares authorized decreased by 0.0% year-over-year, from $5M to $5M.
What is the long-term trend for EXOZ's preferred stock, shares authorized?
Over 2 years (2023 to 2025), EXOZ's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $5M to $5M.